KaydedilenlerDerginizi ekleyin

Dergiler / Bezmiâlem Science / 2020 / Cilt: 8 - Sayı: 3

SARS CoV-2 Pathogenesis and Immune Response

The agent responsible for the epidemic that first appeared in Wuhan, China, in December 2019 was detected to be the new coronavirus (2019-nCoV). Later, the virus that caused respiratory tract infection was discovered to be a member of the beta-cor

Harika DİNÇ
Pelin YÜKSEL MAYDA
Sayfa
98–101
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This review presents an overview of SARS-CoV2 and aims to examine its intracellular pathogenesis and host immune responses.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The agent responsible for the epidemic that first appeared in Wuhan, China, in December 2019 was detected to be the new coronavirus (2019-nCoV).
📊
Temel Bulgular & Veri:Later, the virus that caused respiratory tract infection was discovered to be a member of the beta-coronavirus family, it was named as severe acute respiratory syndrome-CoV2 (SARS-CoV 2), and the disease it caused was called CoV infection disease-19 (COVID-19).
💡
Sonuç & Katkı:This review presents an overview of SARS-CoV2 and aims to examine its intracellular pathogenesis and host immune responses.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

The agent responsible for the epidemic that first appeared in Wuhan, China, in December 2019 was detected to be the new coronavirus (2019-nCoV). Later, the virus that caused respiratory tract infection was discovered to be a member of the beta-coronavirus family, it was named as severe acute respiratory syndrome-CoV2 (SARS-CoV 2), and the disease it caused was called CoV infection disease-19 (COVID-19). The epidemic started in China, spread rapidly first to East Asian countries, then Europe and America, affected the whole world, and was declared a pandemic by the World Health Organization. This review presents an overview of SARS-CoV2 and aims to examine its intracellular pathogenesis and host immune responses.

Abstract

İlk kez Çin’in Wuhan kentinde Aralık 2019’da ortaya çıkan salgından sorumlu olan etkenin yeni koronavirüs (2019-nCoV) olduğu saptanmıştır. Daha sonra, solunum yolu enfeksiyonuna yol açan bu virüsün beta-CoV ailesine ait olduğu belirlenip, şiddetli akut solunum yolu enfeksiyonu-koronavirüs-2 (SARS-CoV-2) olarak adlandırılmış ve oluşturduğu hastalığa da koronavirüs enfeksiyon hastalığı-19 (COVİD-19) denilmiştir. Çin’de başlayan salgın hızla Doğu Asya ülkelerine sonrasında Avrupa ve Amerika’ya yayılarak, tüm dünyayı etkisi altına almış ve Dünya Sağlık Örgütü tarafından pandemi olarak ilan edilmiştir. Bu derleme, bu virüsle ilgili genel bir bakış açısı sunmakla birlikte, hücre içindeki patogenezini ve konak immün yanıtlarını incelemeyi amaçlamıştır.

🔖

Bu Makaleye Atıf Yap

DİNÇ, H., MAYDA, P. Y. (2020). SARS CoV-2 Pathogenesis and Immune Response. Bezmiâlem Science, Cilt: 8 - Sayı: 3, 98–101. https://ajindex.com/articles/406561

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490-502
  2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3
  3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74
  4. World Health Organization. (2020). https://www.who.int/dg/ speeches/detail/who-director-general-s-opening-remarks-at-themission-briefing-on-covid-19---12-march-2020
  5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032. [Epub ahead of print] 6. World Health Organization, Coronavirus disease (COVID-19) pandemic. (2020). Last Accessed Date: 30.06.2020 Available from:
  6. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91-8
  7. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. New York: Springer; 2015:1-23
  8. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020;181:281-92
  9. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 2011;85:4122-34
  10. Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein. J Virol 2014;88:1293-307
  11. Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher TA. Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry J Virol 2011;85:873-82
  12. Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr 2020;14:407-12
  13. Lauer SA, Grantz KH, B